1. From the Department of Pediatrics, Division of Pediatric Nephrology and Hypertension (K.L.M., J.S., C.B., T.P., R.J.P.), and Department of Pediatrics, Division of Pediatric Cardiology (M.G.-M.), School of Medicine, University of Texas, Houston; Wyle Laboratories (K.G.), Houston, Tex; and AstraZeneca Pharmaceuticals, Wilmington, Del (J.M.S.).